echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Make new progress!

    Make new progress!

    • Last Update: 2022-06-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    iNature heterogeneous nuclear ribonucleoproteins (hnRNPs) are a family of RNA-binding proteins that play important roles in various biological processes
    .

    However, the roles of members of hnRNPs in immunity and inflammation remain to be fully understood
    .

    On April 13, 2022, the Chinese Academy of Medical Sciences/Peking Union Medical College Cao Xuetao team published a research paper titled "RNA-binding protein hnRNP UL1 binds κB sites to attenuate NF-κB-mediated inflammation" in the Journal of Autoimmunity.
    The study The hnRNP UL1 was identified as a negative regulator of NF-κB-mediated inflammation by functional screening of hnRNPs members in LPS-stimulated macrophage inflammatory responses
    .

    hnRNP UL1 restricts NF-κB-triggered transcriptional expression of proinflammatory cytokines to innate stimuli
    .

     Perturbation of hnRNP UL1 enhances proinflammatory cytokine production in macrophages
    .

    Deficiency of hnRNP UL1 in vivo increases proinflammatory cytokine production upon exposure to LPS
    .

    Therefore, the expression of hnRNP UL1 is decreased in peripheral blood mononuclear cells of rheumatoid arthritis patients
    .

    Mechanistically, hnRNP UL1 competes with NF-κB for binding to the κB site to limit the magnitude and duration of the inflammatory response
    .

    Meanwhile, extensive dynamic binding of hnRNP UL1 to target gene promoters was revealed during the inflammatory response
    .

    In conclusion, this study adds new insights into the role of hnRNPs in NF-κB-mediated inflammation, suggesting a potential therapeutic strategy to control inflammatory autoimmune diseases
    .

    On March 28, 2022, Hou Jin and Cao Xuetao of Naval Medical University jointly published a research paper entitled "Malignant progression of liver cancer progenitors requires KAT7-acetylated and cytoplasm-translocated G-protein GαS" in Hepatology (IF=17) , which used quantitative mass spectrometry-based methods to screen non-aggregated hepatocytes and HcPC-containing aggregates from a DEN-induced HCC mouse model for proteomic analysis to elucidate dysregulated proteins in HcPC
    .

    This study found that the malignant progression of HcPCs requires increased K28 acetylation and cytoplasmic translocation of GαS, resulting in an enhanced response to IL-6 and driving precancerous HcPCs to fully establish HCC, which provides mechanistic insights and potential targets for the prevention of hepatocarcinogenesis ( click to read)
    .

    An appropriate inflammatory response is necessary to eliminate inflammatory stimuli and repair damaged tissue
    .

    However, unresolved or long-standing adverse inflammation can lead to chronic inflammation, cancer, or autoimmune disease
    .

    Since cytokines produced by activated immune cells play a key role in regulating inflammation, blockade agents targeting some pro-inflammatory cytokines, including TNF-α, IL-6, and IL-1β, have been shown to be inflammatory autologous Effective therapy for immune diseases
    .

    In particular, IL-6 has received much attention due to its pleiotropic functions and widespread involvement in inflammatory diseases including rheumatoid arthritis (RA) and Castleman's disease
    .

    In addition to chronic inflammatory diseases and cancer, IL-6 serum levels have been an important indicator for assessing the severity of infectious diseases, including COVID-19
    .

    Tocilizumab, a humanized monoclonal antibody targeting the IL-6 receptor, has been shown to improve clinical outcomes in severe and critically ill COVID-19 patients, in addition to its use in the treatment of autoimmune diseases
    .

    Nevertheless, in order to better alleviate the inflammatory pathological damage caused by such autoimmune diseases or infectious diseases, the underlying mechanism of its anti-inflammatory effect remains to be further studied
    .

    Transcriptional or post-transcriptional regulation of inflammatory cytokines has long been regarded as a direct factor determining the outcome of inflammation
    .

    The transcription factor NF-κB has been reported to effectively trigger a large number of pro-inflammatory cytokines
    .

    However, the negative regulator value of pro-inflammatory cytokines that may exhibit anti-inflammatory functions remains to be further investigated
    .

    Schematic diagram of the article (picture from Journal of Autoimmunity) Heterogeneous nuclear ribonucleoproteins (hnRNPs) are a large class of RNA-binding proteins that are important in many aspects of nucleic acid metabolism
    .

    In addition to their abundance in the nucleus, features including RNA-binding domains, helper domains, and shuttling between the nucleus and cytoplasm define the general characteristics of hnRNPs
    .

    hnRNP A2/B1 recognizes pathogenic DNA and initiates IFN-α/β production
    .

    SAFA (aka hnRNP U) has been reported to monitor viral RNA and promote immunity by activating antiviral enhancers and super-enhancers
    .

    Although the functions of hnRNPs beyond RNA metabolism have been widely reported, the role of hnRNPs in the regulation of inflammation remains to be elucidated
    .

    To systematically study the role of hnRNPs in the regulation of inflammation, functional screening of 26 hnRNPs, including typical hnRNPs and hnRNPs-like proteins, was performed
    .

    This study used Il6 mRNA expression as a readout to decipher the role of hnRNP in LPS-stimulated inflammatory responses in mouse primary peritoneal macrophages
    .

     With this approach, the study identified hnRNP UL1 as an important suppressor of proinflammatory cytokine production
    .

    In vivo experimental validation and in vitro analysis of clinical samples support a critical role of hnRNP UL1 in suppressing inflammation
    .

    This study found that hnRNP UL1 binds to the κB site to antagonize NF-κB binding, thereby inhibiting the transcription of inflammatory cytokines during the inflammatory response
    .

    In conclusion, this study adds new insights into the role of hnRNPs in NF-κB-mediated inflammation, suggesting a potential therapeutic strategy to control inflammatory autoimmune diseases
    .

    Reference message: https://doi.
    org/10.
    1016/j.
    jaut.
    2022.
    102828
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.